Oligometastatic Prostate Carcinoma

specific

A prostate carcinoma that has metastasized to a limited number of sites.

35

Centers

37

Active Trials

Cancer Funding

Top Centers for Oligometastatic Prostate Carcinoma(35)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
72.6
2
High-Volume Research Center
72.6
3
NCI Comprehensive
Active Research Program
50.1
4
NCI Comprehensive
Active Research Program
50.1
5
NCI Comprehensive
Active Research Program
50.1
6
NCI Comprehensive
Active Research Program
50.1
7
NCI Comprehensive
Active Research Program
50.1
850.1
9
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
50.1
10
NCI Comprehensive
Active Research Program
50.1
11
NCI Comprehensive
Active Research Program
50.1
12
NCI Comprehensive
Active Research Program
50.1
13
NCI Comprehensive
Active Research Program
50.1
14
NCI Comprehensive
Active Research Program
50.1
15
NCI Comprehensive
Active Research Program
50.1
16
NCI Clinical
Active Research Program
50.1
17
NCI Comprehensive
Active Research Program
50.1
18
NCI Comprehensive
Active Research Program
50.1
19
Active Research Program
50.1
20
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
50.1
21
NCI Comprehensive
Active Research Program
50.1
22
NCI Clinical
Active Research Program
50.1
23
Active Research Program
50.1
24
NCI Comprehensive
Active Research Program
50.1
25
Active Research Program
50.1
26
NCI Comprehensive
Active Research Program
50.1
27
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
50.1
28
Active Research Program
50.1
29
Active Research Program
50.1
30
Active Research Program
50.1
31
Active Research Program
50.1
32
Active Research Program
50.1
33
Active Research Program
50.1
34
BC CancerVancouver, BC
Active Research Program
50.1
35
Active Research Program
50.1

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →